NANOVIRICIDES, INC. financial data

Symbol
NNVC on NYSE
Location
Shelton, CT
Fiscal year end
30 June
Latest financial report
10-Q - Q4 2025 - 17 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 224% % -33%
Debt-to-equity 12% %
Return On Equity -96% % -9.4%
Return On Assets -84% % -7.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21,595,000 shares 34%
Common Stock, Shares, Outstanding 21,595,187 shares 38%
Entity Public Float $21,530,000 USD 90%
Common Stock, Value, Issued $216 USD 38%
Weighted Average Number of Shares Outstanding, Basic 19,850,080 shares 36%
Weighted Average Number of Shares Outstanding, Diluted 19,850,080 shares 36%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $4,571,374 USD -17%
General and Administrative Expense $3,823,245 USD -5.4%
Operating Income (Loss) $8,394,619 USD 12%
Nonoperating Income (Expense) $76,178 USD -53%
Net Income (Loss) Attributable to Parent $8,318,441 USD 11%
Earnings Per Share, Basic -0.47 USD/shares 35%
Earnings Per Share, Diluted -0.47 USD/shares 35%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,150,580 USD 30%
Assets, Current $5,296,565 USD 30%
Property, Plant and Equipment, Net $6,656,439 USD -7.2%
Intangible Assets, Net (Excluding Goodwill) $312,904 USD -2.6%
Assets $12,267,640 USD 6%
Employee-related Liabilities, Current $25,088 USD -4.6%
Accrued Liabilities, Current $48,380 USD -26%
Liabilities, Current $1,195,925 USD 1%
Liabilities $1,200,000 USD 0%
Retained Earnings (Accumulated Deficit) $152,847,638 USD -5.8%
Stockholders' Equity Attributable to Parent $11,071,715 USD 6.6%
Liabilities and Equity $12,267,640 USD 6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,593,855 USD 39%
Net Cash Provided by (Used in) Financing Activities $1,245,319 USD -27%
Net Cash Provided by (Used in) Investing Activities $84,317 USD -80%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 21,595,187 shares 38%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,150,580 USD 30%
Deferred Tax Assets, Valuation Allowance $42,492,044 USD 6.8%
Deferred Tax Assets, Gross $42,492,044 USD 6.8%
Depreciation $609,942 USD -20%
Payments to Acquire Property, Plant, and Equipment $84,317 USD 80%
Property, Plant and Equipment, Gross $15,107,566 USD 0.63%
Deferred Tax Assets, Operating Loss Carryforwards $31,115,532 USD 6%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $163,919,128 USD 5.8%
Amortization of Intangible Assets $8,271 USD 0.05%
Deferred Tax Assets, Net of Valuation Allowance $0 USD